Echothiophate (Phospholine) - Uses, Dose, Side effects, MOA, Brands

Echothiophate is a topically used long-acting cholinesterase inhibitor that is indicated for the treatment of patients with accommodative esotropia and chronic glaucoma.

Echothiophate Uses:

  • Accommodative esotropia:

    • Accommodative component of concomitant esotropias.
  • Elevated intraocular pressure:

    • It reduces elevated intraocular pressure.

 

Echothiophate Dose in Adults

Echothiophate Dose in elevated intraocular pressure: Ophthalmic:

  • Initial: Instill one drop twice daily, in the morning and before sleeping, in the affected eye.
  • Maintenance:
    • The preferable dose is twice daily but a significant result has also been seen with a once-daily dose.
    • Also, alternate doses with 1 dose prior to sleeping has been used as a treatment regimen.

 

Echothiophate Dose in Childrens

Echothiophate Dose in accommodative Esotropia:

  • Children and Adolescents: Ophthalmic:

    • Diagnosis: Instill 1 drop once daily into both eyes before sleeping for 2-3 then taper off the dose.
    • Maximum daily dose:
      • 1 drop once daily in both eyes.
    • Note:
      • Use a lower therapeutic dose.
      • The dose can be increased according to the severity of the disease.

 

Echothiophate Pregnancy Risk Category: C

  • Studies on animal reproduction have not been done.

Use of echothiophate while breastfeeding

  • It is unknown if Ecothiophate is secreted in breast milk.
  • It is up to the mother to decide if it should be given to breastfeeding mothers. 
  • It all depends on the severity and importance of the drug for the mother's treatment.

 

Dose in Kidney Disease:

  • There are no dosage adjustments provided in the manufacturer's labeling.

 

Dose in Liver disease:

  • There are no dosage adjustments provided in the manufacturer's labeling.

 

Side effects of Echothiophate.

  • Cardiovascular:

    • Bradycardia
    • Cardiac Abnormality
    • Flushing
    • Hypotension
  • Central Nervous System:

    • Brow Ache
    • Myasthenia
  • Dermatologic:

    • Diaphoresis
  • Gastrointestinal:

    • Diarrhea
    • Nausea
    • Vomiting
  • Ophthalmic:

    • Blepharospasm
    • Blurred Vision
    • Burning Sensation Of Eyes
    • Cataract
    • Conjunctival Abnormalities (Thickening)
    • Conjunctival Erythema
    • Eye Redness
    • Increased Intraocular Pressure (Paradoxical)
    • Iris Cyst
    • Iritis (Latent)
    • Lacrimal Duct Obstruction (Nasolacrimal Canal)
    • Lacrimation
    • Miosis
    • Myopia
    • Retinal Detachment
    • Stinging Of Eyes
    • Uveitis (Activation)
  • Respiratory:

    • Dyspnea

 

Contraindications to Echothiophate:

  • Any allergic reaction to the drug's formulation.
  • Angle-closure Glaucoma is not possible without iridectomy. This is due to active inflammation and increasing angle block.

Warnings and precautions

  • Cardiac irregularities

    • If you experience cardiac irregularities, discontinue use permanently
  • Cholinergic effects

    • Do not take cholinergic activity symptoms (eg, urine incontinence, sweating or salivation) and discontinue use.
    • Overdosage can mimic myasthenia gravis, which should be recognized.
  • Asthma

    • Patients with asthma should not use this product.
  • Cardiovascular disease

    • Patients with recent MI, bradycardia, or hypotension should not use this medication.
    • According to the American Heart Association's scientific statement, ophthalmic cholesterol agents may increase myocardial dysfunction.
  • Gastrointestinal Disease:

    • Patients with GIT disorders, e.g peptic ulcer, are not recommended.
  • Parkinsonism

    • Patients with Parkinsonism should not use this product.
  • Seizure disorder:

    • Patients with seizure history or epilepsy are not recommended.
  • Vagotonia

    • Patients with vagotonia should not use this product.

 

Echothiophate: Drug Interaction

Note: Drug Interaction Categories:

  • Risk Factor C: Monitor When Using Combination
  • Risk Factor D: Consider Treatment Modification
  • Risk Factor X: Avoid Concomitant Use

Risk Factor C (Monitor therapy).

Cyclopentolate Echothiophate Iodide may have a less therapeutic effect.
Mivacurium Echothiophate Iodide can increase serum levels of Mivacurium

Risk Factor D (Consider therapy modifications)

Succinylcholine Echothiophate iodide can increase the serum level of succinylcholine. Management: For patients receiving echothiophate iodide eye drops, consider using a neuromuscular-blocking agents other than succinylcholine. Consider a lower dose of succinylcholine and keep an eye out for prolonged or enhanced effects.

 

Monitoring parameters:

  • When treating esotropias routine lens examination is required.
  • It is important to measure the anterior chamber angle and intraocular pressure at different times of the day.

 

How to administer Echothiophate?

Ophthalmic:

  • Efficacy depends on the proper way of administration.
  • After instilling the drops compress the nasolacrimal duct for 1-2 mins. Remove excess fluid by using a napkin or tissue after instillation.

 

Mechanism of action of Echothiophate:

  • Inhibition of cholinesterase increases the activity of endogenous Acetylcholine. 
  • An increase in the destruction acetylcholine results in stimulation of theciliary muscle, which produces miosis.
  • Other effects include potentiation and an increased aqueous humor flow that causes a decrease intraocular pressure.

The beginning of action:

  • Miosis: ≤60 minutes

Peak effect: Intraocular pressure decrease:

  • After 24 hours

Duration:

  • Miosis: 1 to 4 weeks;
  • Intraocular pressure: Days to weeks.

 

International Brand Names of Echothiophate:

  • Phospholine Iodide
  • Phospholine Jodide
  • Phospholinjodid

 

Echothiophate Brand Names in Pakistan:

No Brands Available in Pakistan.

Comments

NO Comments Found